C. Wagenvoort and N. Wagenvoort, Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases, Circulation, vol.42, issue.6, pp.1163-1171, 1970.
DOI : 10.1161/01.CIR.42.6.1163

S. Eddahibi, V. Fabre, C. Boni, M. Martres, B. Raffestin et al., Induction of Serotonin Transporter by Hypoxia in Pulmonary Vascular Smooth Muscle Cells : Relationship With the Mitogenic Action of Serotonin, Circulation Research, vol.84, issue.3, pp.329-336, 1999.
DOI : 10.1161/01.RES.84.3.329

E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle et al., Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension, Circulation Research, vol.94, issue.9, pp.1263-1270, 2004.
DOI : 10.1161/01.RES.0000126847.27660.69

S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, M. Darmon et al., Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension, Journal of Clinical Investigation, vol.108, issue.8, pp.1141-1150, 2001.
DOI : 10.1172/JCI200112805

J. Newman, R. Trembath, J. Morse, E. Grunig, J. Loyd et al., Genetic basis of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, pp.33-39, 2004.
DOI : 10.1016/j.jacc.2004.02.028

M. Maclean, G. Deuchar, M. Hicks, I. Morecroft, S. Shen et al., Overexpression of the 5-Hydroxytryptamine Transporter Gene: Effect on Pulmonary Hemodynamics and Hypoxia-Induced Pulmonary Hypertension, Circulation, vol.109, issue.17, pp.2150-2155, 2004.
DOI : 10.1161/01.CIR.0000127375.56172.92

S. Eddahibi, N. Hanoun, L. Lanfumey, K. Lesch, B. Raffestin et al., Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene, Journal of Clinical Investigation, vol.105, issue.11, pp.1555-1562, 2000.
DOI : 10.1172/JCI8678

A. Keegan, I. Morecroft, D. Smillie, M. Hicks, and M. Maclean, Contribution of the 5-HT1B Receptor to Hypoxia-Induced Pulmonary Hypertension: Converging Evidence Using 5-HT1B-Receptor Knockout Mice and the 5-HT1B/1D-Receptor Antagonist GR127935, Circulation Research, vol.89, issue.12, pp.1231-1239, 2001.
DOI : 10.1161/hh2401.100426

J. Launay, P. Herve, K. Peoc-'h, C. Tournois, J. Callebert et al., Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension, Nature Medicine, vol.13, issue.10, pp.1129-1135, 2002.
DOI : 10.1038/76282

P. Harris and D. Heath, The Human Pulmonary Circulation. Its Form and Function in Health and Disease, Anesthesiology, vol.24, issue.5, pp.403-432
DOI : 10.1097/00000542-196309000-00035

R. Tuder and N. Voelkel, Pulmonary hypertension and inflammation, Journal of Laboratory and Clinical Medicine, vol.132, issue.1, pp.16-24, 1998.
DOI : 10.1016/S0022-2143(98)90020-8

N. Voelkel, R. Tuder, J. Bridges, and W. Arend, Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline., American Journal of Respiratory Cell and Molecular Biology, vol.11, issue.6, pp.664-675, 1994.
DOI : 10.1165/ajrcmb.11.6.7946395

H. Kimura, O. Okada, N. Tanabe, Y. Tanaka, M. Terai et al., Plasma Monocyte Chemoattractant Protein-1 and Pulmonary Vascular Resistance in Chronic Thromboembolic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.2, pp.319-324, 2001.
DOI : 10.1164/ajrccm.164.2.2006154

P. Baumann, Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???, Clinical Pharmacokinetics, vol.31, issue.6, pp.444-469, 1996.
DOI : 10.2165/00003088-199631060-00004

U. Scheffel, S. Kim, E. Cline, and M. Kuhar, Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: In vivo studies with [125i]rti-55, Synapse, vol.93, issue.4, pp.263-268, 1994.
DOI : 10.1002/syn.890160403

S. Koch, K. Perry, D. Nelson, R. Conway, P. Threlkeld et al., R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus An in vivo Microdialysis and Receptor Binding Study, Neuropsychopharmacology, vol.27, issue.6, pp.949-959, 2002.
DOI : 10.1016/S0893-133X(02)00377-9

L. Hall, G. Anderson, and D. Cohen, Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover, Life Sciences, vol.57, issue.8, pp.791-801, 1995.
DOI : 10.1016/0024-3205(95)02007-6

M. Collu, A. Poggiu, P. Devoto, and G. Serra, Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats, European Journal of Pharmacology, vol.322, issue.2-3, pp.123-127, 1997.
DOI : 10.1016/S0014-2999(97)00006-X

E. Marcos, S. Adnot, M. Pham, A. Nosjean, B. Raffestin et al., Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.4, pp.487-493, 2003.
DOI : 10.1164/rccm.200210-1212OC

S. Lee, W. Wang, B. Moore, and B. Fanburg, Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture, Circulation Research, vol.68, issue.5, pp.1362-1368, 1991.
DOI : 10.1161/01.RES.68.5.1362

E. Hironaka, M. Hongo, A. Sakai, E. Mawatari, F. Terasawa et al., Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats, Cardiovascular Research, vol.60, issue.3, pp.692-699, 2003.
DOI : 10.1016/j.cardiores.2003.09.023

R. Kekuda, F. Leibach, T. Furesz, C. Smith, and V. Ganapathy, Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta, J Pharmacol Exp Ther, vol.292, pp.1032-1041, 2000.

S. Ramamoorthy, J. Ramamoorthy, P. Prasad, G. Bhat, V. Mahesh et al., Regulation of the Human Serotonin Transporter by Interleukin-1??, Biochemical and Biophysical Research Communications, vol.216, issue.2, pp.560-567, 1995.
DOI : 10.1006/bbrc.1995.2659

M. Humbert, G. Monti, F. Brenot, O. Sitbon, A. Portier et al., Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension., American Journal of Respiratory and Critical Care Medicine, vol.151, issue.5, pp.1628-1631, 1995.
DOI : 10.1164/ajrccm.151.5.7735624

M. Humbert, G. Monti, M. Fartoukh, A. Magnan, F. Brenot et al., Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients, Eur Respir J, vol.11, pp.554-559, 1998.